β-肾上腺素能受体阻滞剂是心血管系统药物中重要的一类,在国外的药物研究中,这是最活跃的领域之一。近年来随着心血管药理学研究取得的进展、不断地促进了心血管系统新药研究的迅猛发展,许多新的β-阻滞剂不断问世,并在临床上取得了明显的疗效。现将国外近年来开发和上市的几种新的β-阻滞剂综合简要介绍如下: 1.美多心安Metoprolol Beta-adrenergic receptor blockers are an important class of cardiovascular drugs, which is one of the most active fields in drug research abroad. In recent years, with the progress made in the research of cardiovascular pharmacology, and constantly promoted the rapid development of new cardiovascular drug research, many new β-blockers continue to come out and clinically achieved significant results. Now in foreign countries in recent years, the development and listing of several new β-blocker synthesis are summarized as follows: 1. Metoprolol Metoprolol